ConductScience.org, home

Paper36901633

Prevalence of Diabetic Retinopathy and Use of Common Oral Hypoglycemic Agents Increase the Risk of Diabetic Nephropathy-A Cross-Sectional Study in Patients with Type 2 Diabetes.

Luo WM and 3 others. Int J Environ Res Public Health, 2023. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Prevalence of Diabetic Retinopathy and Use of Common Oral Hypoglycemic Agents Increase the Risk of Diabetic Nephropathy-A Cross-Sectional Study in Patients with Type 2 Diabetes. Papers, record 36901633. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36901633

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prevalence of Diabetic Retinopathy and Use of Common Oral Hypoglycemic Agents Increase the Risk of Diabetic Nephropathy-A Cross-Sectional Study in Patients with Type 2 Diabetes.
PubMed
Journal
Int J Environ Res Public Health
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.97
iCite
Revised in PubMed
2023-03-20
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Luo WMWei-Ming
2Su JYJing-Yang
3Xu TTong
4Fang ZZZhong-Ze

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 2Major topic
Diabetic NephropathiesMajor topic
Diabetic RetinopathyMajor topic
Humans
Cross-Sectional Studies
Prevalence
Hypoglycemic Agents
Risk Factors

Source PubMed

Download CSV of topics

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132883686Plasma phenylalanine and tyrosine and their interactions with diabetic nephropathy for risk of diabetic retinopathy in type 2 diabetes.BMJ Open Diabetes Res Care2020https://conductscience.org/library/papers/32883686PubMed
22079312Acarbose treatment and diabetic nephropathy in the Cohen diabetic rat.Horm Metab Res1990https://conductscience.org/library/papers/2079312PubMed
334469084The link between homocysteine, folic acid and vitamin B12 in chronic kidney disease.G Ital Nefrol2021https://conductscience.org/library/papers/34469084PubMed
429728717Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial.Diabetologia2018https://conductscience.org/library/papers/29728717PubMed
524534450Association between homocysteine status and the risk of nephropathy in type 2 diabetes mellitus.Clin Chim Acta2014https://conductscience.org/library/papers/24534450PubMed
62969913Incidence of retinopathy in type I (insulin-dependent) diabetes: association with clinical nephropathy.J Diabet Complications1987https://conductscience.org/library/papers/2969913PubMed
732267079An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines.Diabetes Obes Metab2020https://conductscience.org/library/papers/32267079PubMed
831129667Diabetic Retinopathy in the Context of Patients with Diabetes.Ophthalmic Res2019https://conductscience.org/library/papers/31129667PubMed
927382338The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies.Clin Pharmacol2016https://conductscience.org/library/papers/27382338PubMed
1012774164Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes.Diabetologia2003https://conductscience.org/library/papers/12774164PubMed
1120488910Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial.BMJ2010https://conductscience.org/library/papers/20488910PubMed
1231505379Predicting the onset of type 2 diabetes using wide and deep learning with electronic health records.Comput Methods Programs Biomed2019https://conductscience.org/library/papers/31505379PubMed
1328432319Diabetic Retinopathy and Clinical Parameters Favoring the Presence of Diabetic Nephropathy could Predict Renal Outcome in Patients with Diabetic Kidney Disease.Sci Rep2017https://conductscience.org/library/papers/28432319PubMed
1410867532Effect of acarbose on blood glucose and proteinuria in patients with diabetic nephropathy.Nephron2000https://conductscience.org/library/papers/10867532PubMed
1533633688The Association Between Leucine and Diabetic Nephropathy in Different Gender: A Cross-Sectional Study in Chinese Patients With Type 2 Diabetes.Front Endocrinol (Lausanne)2020https://conductscience.org/library/papers/33633688PubMed
1623093684
Rate and determinants of association between advanced retinopathy and chronic kidney disease in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study.
Diabetes Care2012https://conductscience.org/library/papers/23093684PubMed
1719804622The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modelling study.BMC Endocr Disord2009https://conductscience.org/library/papers/19804622PubMed
1823424866[Effect of the folic acid and vitamin B2 on the diabetes mellitus rats with diabetic nephropathy].Wei Sheng Yan Jiu2012https://conductscience.org/library/papers/23424866PubMed
1933478336The predictive value of diabetic retinopathy on subsequent diabetic nephropathy in patients with type 2 diabetes: a systematic review and meta-analysis of prospective studies.Ren Fail2021https://conductscience.org/library/papers/33478336PubMed
2011733625Renal function and structure in albuminuric type 2 diabetic patients without retinopathy.Nephrol Dial Transplant2001https://conductscience.org/library/papers/11733625PubMed

See all 41 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
41821728Changes of retinal microvascular parameters in patients with type 2 diabetes mellitus with or without diabetic kidney disease.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/41821728PubMed
40385017Predictive value of liver and kidney function and bone metabolism markers for postoperative outcomes in diabetic retinal surgery.Am J Transl Res2025https://conductscience.org/library/papers/40385017PubMed
38275038Diabetic Retinopathy Leading to Blindness- A Review.Curr Diabetes Rev2024https://conductscience.org/library/papers/38275038PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FOXO12308PubTator's text mininghttps://conductscience.org/library/genes/2308NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
PRKAA15562PubTator's text mininghttps://conductscience.org/library/genes/5562NCBI Gene
SIRT123411PubTator's text mininghttps://conductscience.org/library/genes/23411NCBI Gene
SNAI16615PubTator's text mininghttps://conductscience.org/library/genes/6615NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36901633

GET https://conductscience.org/api/papers/v1/36901633/references?page=2